2018 All Hands Meeting
October 15 Session
Life Sciences Track Agenda

9:00AM-10:00AM   Room 201

SPEAKER BIOGRAPHIES


10:30AM-12:00PM   Room 201
FDA Update/Life Science Company Collaborations

Joshua Hofheimer & Emily Marden
Sidley Austin LLP
SPEAKER BIOGRAPHIES

Twofer: This presentation combines an FDA update with a discussion of the ongoing shift in how life science companies are approaching strategic collaborations to maximize the conditions for success.

1:30PM-2:15PM   Room 201
Distributed Ledger Technology: A Guide for the Perplexed

Samuel Dibble
Baker Botts LLP
SPEAKER BIOGRAPHIES

An easy to understand overview of cryptocurrencies, tokens, blockchain and other applications of distributed ledger technology. Learn about exciting recent developments in the use of this technology and innovations in how funds are raised, including recent trends in ICOs, SAFTs and token pre-sales. We will also discuss the securities, tax and consumer protection issues raised by these innovations.

2:20PM-3:05PM   Room 201
Fintech and the EU

Gina Conheady
A&L Goodbody
SPEAKER BIOGRAPHIES

Tech saavy in-house counsel know that the fintech technological revolution is global, but that regulations and commercial standards of nations and multinational blocs are not all adapting at the same pace, or in the same ways. This presentation will focus on significant differences in the European approach to fintech, and ways that legal strategies can successfully accommodate those differences as companies grow in Europe.

3:30PM-4:30PM   Room 203/204
FCPA Update

Brendan Cullen & Laura Oswell
Sullivan & Cromwell LLP
SPEAKER BIOGRAPHIES

In recent quarters the DOJ and SEC seem to have been easing off pedal-to-the-metal growth in number and reach of Foreign Corrupt Practice Act enforcement actions. Is this statistical noise or a lasting policy turn that in-house counsel should factor into their plans and policies for international operations? This discussion will assess recent developments in geographic focus, declination policy, and other factors affecting FCPA enforcement, and how they fit into strategic global risk management.


Please Note: Program details are subject to change without notice

2018 Participating Law Firms & Companies